This announcement is a separate document:
海得控制：关于本次交易构成关联交易的说明
Hyde Control: Explanation that this transaction constitutes a related transaction
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
23:23
UN Institutions: Approximately 30.4 million people in Sudan will need humanitarian assistance in 2025.
23:22
The Russian Ministry of Internal Affairs: The New Year celebrations in Russia were safe and sound.
23:21
SH PHARMA has terminated three clinical trial projects in the USA, with total R&D investments exceeding 80 million yuan.
SH PHARMA0.00%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.